<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03137472</url>
  </required_header>
  <id_info>
    <org_study_id>25894-3</org_study_id>
    <nct_id>NCT03137472</nct_id>
  </id_info>
  <brief_title>TMS for Complex Regional Pain Syndrome</brief_title>
  <official_title>Transcranial Magnetic Stimulation (TMS) for Complex Regional Pain Syndrome (CRPS)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stanford University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institutes of Health (NIH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>Redlich Pain Endowment</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Rocky Mountain Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Feldman Family Foundation Pain Research Fund</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Stanford University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>No</is_unapproved_device>
    <is_ppsd>No</is_ppsd>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the current study is to assess the efficacy of TMS in the treatment of Complex
      Regional Pain Syndrome (CRPS). It is hypothesized that participants who receive TMS (Group 1)
      relative to sham treatment (Group 2) once daily for two days will demonstrate a greater
      improvement in CRPS-related pain and other associated symptomology (i.e., cognitive,
      emotional and physical) compared to baseline. Participants will be followed until they reach
      their baseline for two consecutive weeks to assess safety and duration of symptom
      alleviation.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 24, 2017</start_date>
  <completion_date type="Anticipated">June 29, 2018</completion_date>
  <primary_completion_date type="Anticipated">June 29, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
    <masking_description>Single, blinding of participant</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Pain</measure>
    <time_frame>1 week follow-up compared to baseline</time_frame>
    <description>Decrease in CRPS-related Pain Ratings</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Duration of Pain Relief</measure>
    <time_frame>Duration from last treatment until pain returns - up to an estimate of 6 months</time_frame>
    <description>Duration of decreased CRPS-related pain ratings, measured as a length of time until pain returns for two consecutive weeks</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Pain-related Symptomology</measure>
    <time_frame>Duration from last treatment until pain returns - up to an estimate of 6 months</time_frame>
    <description>Decreases in Pain-related Symptomology (i.e., cognitive, emotional and physical)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Complex Regional Pain Syndromes</condition>
  <arm_group>
    <arm_group_label>Active Treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will receive active TMS in the target area once daily for two days</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham Treatment</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Participants will receive active TMS in a non-target area once daily for two days</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Transcranial Magnetic Stimulation (TMS)</intervention_name>
    <description>The Magventure TMS stimulator will be used to perform intermittent theta burst followed by high frequency Transcranial Magnetic Stimulation (TMS).</description>
    <arm_group_label>Active Treatment</arm_group_label>
    <arm_group_label>Sham Treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 18-70

          -  Diagnosis of CRPS (complex regional pain syndrome) for at least 3 months

          -  Average pain level reported on Numerical Rating Scale meets entry criteria

          -  Ability to perform the experimental task and procedures.

        Exclusion Criteria:

          -  MRI contraindication (metal implants or devices, claustrophobia)

          -  TMS Contraindication (eg metal implant or devices near the site of stimulation)

          -  History of epilepsy

          -  History of a psychological or psychiatric disorder that would interfere with study
             procedures, at the discretion of the researcher.

          -  Neurologic illness that would interfere with brain integrity

          -  Current medical condition or medication use that would interfere with study procedures
             or data integrity, at the discretion of the researcher.

          -  Currently pregnant or planning to become pregnant.

          -  On going legal action or disability claim.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Kristen H Scherrer</last_name>
    <phone>650-724-2091</phone>
    <email>khymel@stanford.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Stanford Pain Management Center</name>
      <address>
        <city>Redwood City</city>
        <state>California</state>
        <zip>94043</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kristen H Scherrer</last_name>
      <phone>650-724-2091</phone>
      <email>khymel@stanford.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 28, 2017</study_first_submitted>
  <study_first_submitted_qc>April 28, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 2, 2017</study_first_posted>
  <last_update_submitted>November 7, 2017</last_update_submitted>
  <last_update_submitted_qc>November 7, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 8, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Stanford University</investigator_affiliation>
    <investigator_full_name>Sean Mackey</investigator_full_name>
    <investigator_title>Chief, Division of Pain Medicine</investigator_title>
  </responsible_party>
  <keyword>TMS, CRPS, Sham</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Somatoform Disorders</mesh_term>
    <mesh_term>Complex Regional Pain Syndromes</mesh_term>
    <mesh_term>Reflex Sympathetic Dystrophy</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

